The BCR-ABL fusion oncogene, which is responsible for the pathogenesis of CML, has greatly enhanced ABL1 tyrosine kinase constitutive activity [1]. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.